经肱动脉入路单期腔内治疗合并髂动脉与股下动脉外周动脉疾病
前瞻性研究纳入45例有组织缺损的患者,评估经肱动脉入路单次同期行髂动脉与股下动脉腔内血运重建的安全性与有效性。单纯肱动脉入路技术成功率为75.6%,需二次股动脉入路者为20%;1年总生存率93.33%、无截肢生存率84.4%。结论认为该治疗可经肱动脉安全实施,胫动脉闭塞者可能需二次股动脉入路,较大鞘管与入路并发症相关。
要点
- 单纯肱动脉入路技术成功率75.6%,需二次股动脉入路者20%。
- 入路并发症发生率11.1%,仅4.4%需手术修复肱动脉。
- 胫动脉闭塞与肱动脉入路失败显著相关(P < 0.001)。
核心结论
- 合并髂动脉与股下动脉病变可经肱动脉入路安全实施腔内治疗。
- 胫动脉闭塞患者可能需二次股动脉入路以成功恢复足部直接血流。
- 使用较大动脉鞘管与较高的入路并发症发生率相关。
研究设计与样本
- 前瞻性研究,纳入45例有组织缺损的患者。
- 若股下动脉病变无法通过,则使用二次股动脉入路。
主要发现
- 单纯肱动脉入路技术成功率为75.6%,使用二次股动脉入路者为20%。
- 仅1例(2.2%)需右侧肱动脉入路,其余44例经左侧肱动脉入路治疗。
- 入路并发症发生率为11.1%,仅4.4%需手术修复肱动脉。
- 无围手术期死亡,无脑血管事件记录。
- 1年总生存率为93.33%,无截肢生存率为84.4%。
关键数值与推荐
- 单纯肱动脉入路技术成功率75.6%,二次股动脉入路技术成功率20%。
- 入路并发症发生率11.1%,需手术修复肱动脉者4.4%。
- 1年总生存率93.33%,无截肢生存率84.4%。
- 胫动脉闭塞与肱动脉入路失败相关(P < 0.001)。
- 使用7 Fr鞘管与肱动脉入路相关并发症相关(P = 0.019)。
临床怎么用
- 合并髂动脉与股下动脉病变伴组织缺损者,可经肱动脉入路单期行腔内血运重建。
- 胫动脉闭塞患者可能需二次股动脉入路以成功恢复足部直接血流。
- 使用较大(7 Fr)鞘管时需注意肱动脉入路相关并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Combined inflow and outflow disease has become a common pattern in patients with chronic limb-threatening ischemia. Patients with tissue loss require simultaneous correction of inflow and outflow disease to prevent amputation. However, those patients are usually unfit for open surgical or hybrid procedures due to having multiple comorbidities. The aim of this study was to evaluate the safety and effectiveness of combined iliac and infrainguinal endovascular revascularization via brachial access in a single session. METHODS: A prospective study conducted on 45 patients with tissue loss. In case of failure to cross the infrainguinal lesions, a secondary femoral access was used. RESULTS: Technical success was achieved in 75.6% of the patients using brachial access alone and in 20% using secondary femoral access. Only one patient required right brachial access (2.2%), while the remaining 44 patients were treated via left brachial access. Access complications were recorded in 11.1% but only 4.4% required surgical repair of brachial artery. No perioperative mortality and no cerebrovascular events were recorded. At 1 year, the overall and amputation-free survival rates were 93.33% and 84.4%, respectively. Crural artery occlusion was significantly associated with failure of brachial access (P < 0.001). Brachial access-related complications were significantly associated with using larger (7 Fr) sheaths (P = 0.019). CONCLUSION: Endovascular treatment of combined iliac and infrainguinal disease can be safely delivered via brachial access. Patients with crural artery occlusion may need secondary femoral access to successfully restore direct blood flow to the foot. Higher rate of access complications was associated with using larger arterial sheaths.
引用
- Abdelaty MH, El-Mahallawy AM. Single-Stage Endovascular Treatment of Combined Iliac and Infrainguinal Peripheral Arterial Disease Through Brachial Access. Ann Vasc Surg. 2025. PMID: 40441424. doi:10.1016/j.avsg.2025.05.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。